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Abstract Epilepsy affects around 50 million people world-
wide, and in about 65 % of patients, the etiology of disease is
unknown. MicroRNAs are small non-coding RNAs that have
been suggested to play a role in the pathophysiology of
epilepsy. Here, we compared microRNA expression patterns
in the hippocampus using two chronic models of epilepsy
characterised by recurrent spontaneous seizures (pilocarpine
and self-sustained status epilepticus (SSSE)) and an acute 6-
Hz seizure model. The vast majority of microRNAs
deregulated in the acute model exhibited increased expression
with 146 microRNAs up-regulated within 6 h after a single
seizure. In contrast, in the chronic models, the number of up-
regulated microRNAs was similar to the number of down-
regulated microRNAs. Three microRNAs—miR-142-5p,
miR-331-3p and miR-30a-5p—were commonly deregulated
in all three models. However, there is a clear overlap of
differentially expressed microRNAs within the chronic
models with 36 and 15 microRNAs co-regulated at 24 h and
at 28 days following status epilepticus, respectively. Pathway
analysis revealed that the altered microRNAs are associated
with inflammation, innate immunity and cell cycle regulation.
Taken together, the identified microRNAs and the pathways
they modulate might represent candidates for novel molecular
approaches for the treatment of patients with epilepsy.
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Introduction
According to theWorld Health organisation and the International
Bureau for Epilepsy (IBE), epilepsy is a chronic neurologic
disorder that affects 4 to 10 per 1,000 people, with 20–30 % of
them experiencing more than one seizure per month (Forsgren
et al. 2005). Themost common type of focal epilepsy is temporal
lobe epilepsy (TLE) characterised by spontaneous recurrent sei-
zures (SRSs) (Weiss et al. 1986), neuronal loss in the hippocam-
pus and mossy fibre sprouting (Riban et al. 2002). A significant
proportion of patients with TLE are resistant to antiepileptic
drugs (AEDs), which is in stark contrast with the high efficacy
of the same AEDs observed in acute preclinical models of
seizures (Loscher and Schmidt 2011). AEDs not only fail to
generate seizure freedom but are also ineffective in modifying
the process of epileptogenesis especially in high-risk patients
(Benardo 2003; Temkin 2009; Loscher and Schmidt 2011).
Molecular profiling studies have provided insight into the
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molecular changes that contribute to the epileptogenic process, as
well as potential mechanisms, ranging from transcription factors
(McClelland et al. 2011; Mazzuferi et al. 2013) to chromatin
methylation (Kobow and Blumcke 2011) and to small non-
coding RNAs (Jimenez-Mateos et al. 2011, 2012; McKiernan
et al. 2012).
MicroRNAs (miRNAs) are small non-coding RNAs
involved in post-transcriptional regulation of gene ex-
pression (Aravin and Tuschl 2005; Pfeifer and Lehmann
2010). miRNAs are transcribed by RNA polymerase II;
they form a stem-loop structure that is further processed
by a microprocessor complex (including the enzyme
Drosha) into precursor miRNA (Gregory et al. 2006)
and cleaved by RNase III enzyme Dicer into 21–22-
nucleotide (nt) long miRNA duplexes. One strand of the
duplex is loaded onto the RNA-inducing silencing com-
plex (RISC) as mature miRNA that binds to its com-
plementary sequences in the 3′ untranslated region (3′
UTR) of target messenger RNAs (mRNAs). Even partial
complementary binding of the miRNA to the 3′ UTR of
the target mRNA can result in post-transcriptional inhi-
bition. Therefore, one miRNA can regulate potentially
several hundred transcripts (Hutvagner and Zamore
2002; Pillai 2005).
miRNAs have been identified across species and are
thought to play essential roles in a variety of fundamen-
tal cellular processes from cell death to neurogenesis
(Volvert et al. 2012). miRNA numbers increase with
the complexity of the organism suggesting that miRNAs
are contributing to an additional layer of plasticity and a
more sophisticated regulation of gene expression in
higher organisms (Griffiths-Jones et al. 2006; Lee
et al. 2007). Interestingly, miRNAs are generally more
highly abundant in the brain relative to other tissues
(Kosik 2006). Ablation of Dicer in the mouse brain
blocks miRNA biogenesis leading to neuronal loss and
premature death indicating that miRNAs are important
for brain function (Schaefer et al. 2007). Several
miRNAs regulate brain development, cellular function
and neurological diseases (Im and Kenny 2012;
McNeill and Van Vactor 2012; Salta and De Strooper
2012). Furthermore, recent reports identified individual
miRNAs that influence seizure-induced neuronal death
(Jimenez-Mateos et al. 2011, 2012; McKiernan et al.
2012). miRNA profiling studies in epileptic tissues have
revealed highly selective, spatiotemporal changes in ex-
pression patterns; however, inconsistencies between the
deregulated miRNAs have been observed. This is likely
due to differences in species (rat versus mouse) and
models used (chemically versus electrically induced sta-
tus epilepticus (SE)). In addition, different time points
after SE as well as miRNA profiling techniques were
applied. Therefore, additional miRNA profiling studies
are needed to allow a more comprehensive characterisa-
tion of miRNA involvement in epilepsy pathophysiology
(Jimenez-Mateos and Henshall 2013).
Several rodent models of human TLE have been developed
(Turski et al. 1983; Mazzuferi et al. 2012). In these models, a
chemical or electrical stimulus induces SE after which the
animals develop spontaneous recurrent epileptic seizures
(SRS), a hallmark of chronic epilepsy. These animals display
signs of hippocampal reorganisation, neuronal loss and neu-
roinflammation with some similarity to different stages of the
human disease. In addition, seizures emanating from temporal
lobe structures can be elicited by electrical stimulation in naïve
animals, which otherwise do not display any TLE-related
pathology. One important example of such an approach is
the 6-Hz seizure model, in which naïve mice display brief
focal (limbic) convulsions after acute electrical stimulation
(Barton et al. 2001). As such, there is a fundamental difference
between post-SE models, where the animals display SRS
(epilepsymodels) andmodels where a single seizure is acutely
induced (seizure models).
For the present study, we took advantage of the differences
between epilepsy and seizure models to delineate common
changes in miRNA expression profiles observed in chronic
epilepsy models (pilocarpine and self-sustained status epilep-
ticus (SSSE)) and after induction of an acute seizure (6-Hz
model). We observed limited overlap between deregulated
miRNAs in the acute seizure model and the chronic models.
However, despite the different stimuli used for induction of
SE (chemical versus electrical), there was a significant overlap
in altered miRNA patterns between the two chronic models.
Pathway analysis revealed a potential involvement of inflam-
mation, innate immunity and cell cycle regulationwhich could
lead to novel therapeutic approaches in epilepsy.
Material and Methods
Ethics Statement
All procedures were carried out according to the Helsinki
declaration and conducted according to the guidelines of the
European Community Council directive 86/609/EEC. The
protocol (reference: PILO-STATUS-EPILEPTICUS-MO,
ELEC-6HZ-SEIZURE-MO, STIM-ELEC-STATUS-EPI-
LEPTICUS-MO) was approved by UCB’s Ethical Committee
for Animal Experimentation (accreditation number from Ser-
vice Public Fédéral Santé publique: LA 122 0040).
Study Design
We compared hippocampal miRNA expression patterns in
twomouse models of chronic epilepsy (pilocarpine and SSSE)
and in an acute seizure model (6 Hz). The expression of 579
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miRNAs was analysed using a miRNA microarray profiling
platform. An outline of the study is depicted in Supplementary
Fig. 1. In both chronic epilepsy models, animals developed
SRS following induction of SE, and samples were taken at an
early time point (i.e. 24 h after induction of SE) and at a late
time point (i.e. 28 days after induction of SE). In the acute
seizure model, animals displayed an acute, single focal sei-
zure, and hippocampal tissuewas dissected at 3, 6, 24 and 72 h
following the acute insult. A detailed bioinformatics analysis
was performed including principal component analysis
(PCA), heat map analysis as well as Venn diagrams for the
analysis of miRNA expression pattern across all three models
at different time points. Significantly deregulated miRNAs
(p<0.05) were validated by quantitative reverse transcription
polymerase chain reaction (RT-qPCR).
Animals
For the chronic epilepsy models, 5–6-week-old male mice
(Charles River) were subjected to two different models of
chronic epilepsy causing SRSs, i.e. pilocarpine and SSSE
models. Selection of an appropriate mouse strain for particular
epilepsy models is critical due to well documented differences
in seizure vulnerability among various mouse strains
(Schauwecker 2011). Therefore, both pilocarpine and SSSE
models had been previously established and optimised in our
lab using two different mouse strains, Naval Medical
ResearchInstitute (NMRI) and C57Bl/6 J, respectively
(Niespodziany et al. 2010; Mazzuferi et al. 2012).
A single injection of pilocarpine was used to trigger SE
in male NMRI mice (28–32 g at the beginning of the study).
As previously described (Mazzuferi et al. 2012), animals
were injected intraperitoneally (i.p.) with 1 mg/kg of N-
methylscopolamine bromide 30 min prior to pilocarpine
treatment (300 mg/kg; i.p.). Within 10 to 45 min after
pilocarpine treatment, animals displayed generalised
clonic-tonic seizures that progressed to continuous convul-
sive activity, i.e. SE. The duration of SE lasted up to 2 h and
was interrupted by i.p. injection of diazepam (10 mg/kg) to
limit the extent of brain damage. The mice surviving SE
typically show SRSs within few days and continue to dis-
play them for several weeks (Mazzuferi et al. 2012). There-
fore, the mice were scarified 24 h after SE induction (early
time point) without monitoring for SRS, while all mice
were continuously video monitored for 28 days and scari-
fied to collect brain samples (late time point) (Supplemen-
tary Figs. 2 and 3). Naïve, age-matched mice of the same
strain were used as controls for each time point.
SSSE is a chronic epilepsy model induced by electrical
stimulation. As previously described (Niespodziany et al.
2010), C57Bl/6 J male mice were surgically implanted with
electroencephalography (EEG) electrodes: depth electrode
(bipolar) AP=−1.40 mm, L=−2.65 mm, D=−5.00 mm;
cortical electrode (monopolar) AP=−4.00 mm, L=+3 mm
and reference electrode in the prefrontal bone. After recovery
from surgery, mice underwent electrical stimulation through
the amygdala-implanted electrode (90-min duration, 100-ms
trains of 1-ms alternating current pulses (50 Hz), 2 trains per
1 s, 250-μA peak current intensity). Upon cessation of elec-
trical stimulation, the animals developed SSSE represented as
continuous convulsive activity that was stopped after 150 min
by i.p. injection of diazepam (10 mg/kg). SRSs typically start
to occur within a few days after SSSE (Niespodziany et al.
2010). By analogy to the pilocarpine model, the mice were
scarified 24 h after SSSE induction (early time point) without
monitoring for SRS, while all mice were continuously video-
EEG monitored for 28 days and scarified to collect brain
samples (late time point) (Supplementary Figs. 2 and 3).
Naïve, age-matched mice of the same strain were used as
controls for each time point. For both the pilocarpine and the
SSSEmodel, eight animals were used per experimental group.
For acute temporal lobe seizures, male NMRI mice were
used. Mice were electrically stimulated to induce a single
seizure activating only temporal lobe structures (Barton et al.
2001). As previously described (Kaminski et al. 2004), sei-
zures were triggered by a stimulator (ECT Unit 57800, Ugo
Basile, Comerio, Italy) using a current intensity of 44 mA,
0.2-ms monopolar pulses at 6-Hz frequency for a duration of
3 s through corneal electrodes. Prior to stimulation, a drop of
saline with 0.1 % Unicaïne was placed on the eyes to ensure
good conductivity and mild anesthesia. After stimulation,
each mouse was observed for convulsive behaviour (i.e. ste-
reotypy, immobility and mild myoclonus), typically lasting
more than 7 s. As controls age-matched, non-stimulated ani-
mals were used. In this model, seven animals per experimental
group were used.
A modified Racine scale (Racine 1972) was used to char-
acterise convulsive motor seizure severity as follows: Stage 3
seizures were defined by forelimb clonus and a lordotic pos-
ture, stage 4 seizures included forelimb clonus and rearing and
stage 5 seizures displayed a stage 4 seizure with loss of the
righting reflex (Williams et al. 2009). For all models, the naive
control animals underwent similar procedures as the treated
animals with the exception of induction of seizure or SE.
Tissue Collection and RNA Isolation
Mice were sacrificed 24 h and 28 days after the induction of
SE in both, pilocarpine and SSSE model. As control groups,
24-h and 28-day time points were used for the pilocarpine
model, and a 28-day time point was used for the SSSE model
for technical reasons. Mice were sacrificed at 3, 6, 24 and 72 h
following acute seizure in the 6-Hzmodel. Mouse hippocampi
were extracted and snap frozen. Total RNAwas isolated from
the sonicated tissue using miRVana miRNA isolation kit
(Ambion Inc., Austin, Texas, USA), and RNA quality was
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verified (Agilent Bioanalyzer Lab-on-a-Chip System) observ-
ing intact 5S, 5.8S and 18S ribosomal RNA. All samples
analysed had an RNA integrity number (RIN) >7.
MicroRNA Microarray
Profiling was performed using the miRCURYTM LNA Array
miRNA on dual-channel arrays (Exiqon A/S) with complete
coverage of miRBase release 14. For pilocarpine and SSSE
models, miRNA microarray profiling was performed at 24 h
and 28 days following SE. For 6-Hz model, miRNAmicroarray
profiling was done at 3, 6, 24 and 72 h after acute seizure. Based
on comparison with the current miRBase® release 20 (Griffiths-
Jones 2006; Griffiths-Jones et al. 2008), all sequences not
representing miRNAs were deleted from the analysis.
Normalisation and Preprocessing
Data were preprocessed and analysed using bioconductor®
(Gentleman et al. 2004) and R® (R Development Core
Team 2011) tools. Red and green intensities and their
respective background values were extracted from two-
channel arrays. In order to avoid negative corrected inten-
sities and to reduce variability of low intensity log-ratios,
the norm exponential convolution method was used for
background correction (Smyth 2005; Ritchie et al. 2007;
Silver et al. 2009). Background-corrected values were then
normalised and summarised to average log intensities and
intensity log-ratios using loess normalisation for within-
array normalisation and quantile normalisation for
between-array normalisation, considering spot quality
weights (Yang et al. 2002; Smyth and Speed 2003; Rao
et al. 2008; Risso et al. 2009). A rigorous quality assess-
ment confirmed the quality of the chips. The GAL file from
Exiqon together with the 20th release of miRBase®
(Griffiths-Jones 2004; Kozomara and Griffiths-Jones
2011) was used for chip annotation. Data sets were
submitted to Gene Expression Omnibus (GEO) with
the following accession numbers: GSE51840 (6-Hz
data set), GSE51841 (pilocarpine data set) and
GSE51842 (SSSE data set).
Differential Expression Analysis
Differential expression analyses for miRNAs were performed
using “limma” linear models for microarray data (Smyth
2005) utilising the empirical Bayes method (Casella 1985).
Statistical dependencies of samples between different condi-
tions and replicates were considered via a factorial design
matrix in limma using a “condition-replicate” factor. Contrasts
were considered for interaction effects. Correlations between
the technical quadruplicates in the chips were taken into
consideration, and spot quality weights were used (manually
flagged spots, empty, poor and negative spots are down-
weighted with 0.7, 0.4, 0.2 and 0.1 factors, respectively).
Corrections for multiple testing were done using Benjamini
and Hochberg’s method (Benjamini and Hochberg 1995).
Significant differentially expressed miRNAs were reported
at FDRBH<0.05. In the differential expression analyses, we
compared pilocarpine-treated mice samples to their counter-
part naive samples at 24 h and 28 days, respectively. SSSE
samples at 24 h and 28 days were compared to a single SSSE
control group. In 6-Hz data, samples at the subsequent time
points (3, 6, 24 and 72 h) were compared to the samples at the
initial time point (0 h).
RT-qPCR
Universal complementary DNA (cDNA) synthesis kits,
SYBR Green master mix and miRCURY LNA Universal
RT murine miRNA PCR primer sets (Exiqon A/S) were used
for quantification of 135b-5p, miR-142-3p, miR-142-5p,
miR-34b-3p, miR-140-5p, miR-212, miR-221, miR-222 and
miR-2137. Synthesis of cDNA was performed according to
Exiqon standard protocols using 20 ng of total RNA. RNA
and cDNA concentrations were measured byNanodrop 2000c
Spectrophotometer (Peqlab Biotechnology). Real-time PCR
reactions were carried out in 384 well plates with 5-μl SYBR
Green master mix, 1 μl of primer mix for each miRNA and
4 μl of 1:80 diluted cDNA per well. Each sample was run in
triplicates for the miRNA of interest as well as for endogenous
controls (RNU6). The real-time PCR assays were performed
on a 7900HT system (Life Technologies). The real-time PCR
settings were 50 °C for 2 min, 95 °C for 10 min, 40 cycles of
95 °C for 10 s followed by 60 °C for 1 min and 25 °C for
1 min. Data were calculated using the ΔΔCt method (Livak
and Schmittgen 2001).
Pathway Analysis
Pathway analysis was conducted with MetaCore™ software
suite (http://thomsonreuters.com/site/systems-biology). This
software employs a dense and manually curated database of
interactions between biological objects and variety of tools for
functional analysis of high-throughput data including pathway
map enrichment (Nikolsky et al. 2005).
First, for all the 728 canonical pathway maps avail-
able in the database, miRNAs binding to the corre-
sponding genes were identified. Only interactions with
a high level of confidence were taken into account
(proven interaction in at least one animal model). Then,
an enrichment analysis was performed comparing the
list of differentially expressed miRNAs with the list of
miRNAs associated to each pathway map. The enrich-
ment analysis was performed using a hyper-geometric
test separately for up- and down-regulated miRNAs. A
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correction for multiple testing was done using Benjamini and
Hochberg’s method (Benjamini and Hochberg 1995), and
significant canonical pathway maps were selected according
to a FDR<0.05.
Results
Relative Comparison of Chronic Epilepsy and Acute Seizure
Models
To analyse whether the two chronic epilepsy models (pilocar-
pine, SSSE) and the acute seizure model (6 Hz) have distinct
miRNA expression profiles, we performed a complete linkage
hierarchical clustering using Euclidean distance as similarity
measure (Fig. 1). This clustering was based on all miRNAs
detected in the expression profiling of the pilocarpine and
SSSE models at the time points 24 h and 28 days as well as
of the 6-Hz model at the time points 3, 6, 24 and 72 h.
The dendrogram (Fig. 1) showed a clear segregation of the
acute seizure and chronic epilepsy models implying a closer
correlation of the miRNA pattern for the two chronic models
than with the acute seizure model. Also, the PCA of all three
models revealed a clustering of the two epilepsy models
versus the seizure model, in accordance with the dendrogram
(Supplementary Fig. 4). Furthermore, for the chronic models,
different time points within a model clustered closer relative to
the same time point in the other SE animals indicating some
model-specific changes in the miRNA expression pattern. In
the 6-Hz model, miRNA expression clustered more closely at
early time points (3 and 6 h) relative to the later time points (24
and 72 h) (Fig. 1). The most prominent difference was ob-
served between the first (3 h) and the last time point at 72 h.
Thus, similar to the chronic model also in the acute model,
subsets of miRNAs were differentially regulated at early and
late time points.
Principal Component Analysis in Chronic Epilepsy and Acute
Seizure Models
A PCA was performed in order to assess the relationship
between samples according to the miRNA expression profiles
(Fig. 2). The PCA was performed for each model separately
including all detected miRNAs. In the pilocarpine model, the
early time point (24 h) and the naïve 24 h formed clearly
separate clusters, while at the later time point (28 days), clus-
tering is less obvious (Fig. 2a). In the SSSE model, the
different groups clustered together with some overlaps includ-
ing one outlier for the early time point (24 h) (Fig. 2b). In the
6-Hz model, the grouping of the samples was less clear.
Nevertheless, the expression of miRNAs in the epileptic ani-
mals is more different to naïve animals 3 and 6 h after a single
seizure as compared to 24 and 72 h (Fig. 2c).
miRNA Expression Pattern in Pilocarpine, SSSE and 6-Hz
Models
Next, we performed a two-way hierarchical clustering using
the top 50 significantly deregulated miRNAs showing a p
value <0.05 (Benjamini and Hochberg corrected) for each
model analysed separately per time point (Fig. 3).
In the pilocarpine model, especially the early time point
(24 h) showed a clear separation compared with naïve animals
(Fig. 3a), while at the later time point (28 days), clustering and
group separation are less pronounced (Fig. 3b). The number of
deregulated miRNAs at 24 h (99) is higher relative to the 28-
day samples, where expression of 51 miRNAs was signifi-
cantly altered (Supplementary Table 1). In the SSSE model,
we observed a clear clustering of naïve and epileptic animals
at 24 h (Fig. 3c). However, a less pronounced clustering was
observed in SSSE animals at 28 days (Fig. 3d).
Whereas in the chronic models, a clear clustering was
observed for the majority of time points; in the 6-Hz model,
this effect was less pronounced at 3 and 6 h after seizure
(Fig. 4a, b). At 24 and 72 h after SE, segregation among
groups was even less evident (Fig. 4c, d). In addition, the total
number of miRNAs with an altered expression level was
significantly reduced at the later period (24 and 72 h) com-
pared to time points immediately after a seizure (3 and 6 h).
Overlapping miRNA Expression Profiles in Seizure Models
To identify miRNAs potentially associated with chronic forms
of epilepsy, we investigated the overlap of miRNA expression
between the two chronic epilepsy models (pilocarpine and
SSSE) and the acute seizure model (6 Hz) using Venn dia-
grams (Fig. 5). Again, the analysis was based on all
Fig. 1 Clustering of miRNAs in different epilepsy mouse models. Hier-
archical clustering of miRNAs extracted frommouse hippocampus of the
pilocarpine and SSSE models 24 h and 28 days following SE, as well as
in the 6-Hz model 3, 6, 24 and 72 h following seizure
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differentially expressed miRNAs (p value <0.05) between
epileptic and control animals within each model.
First, the data for the 24-h time point were compared
among the three models, as this time point is common
to all three models. The Venn diagram showed an
overlap of three miRNAs between the acute and chronic
models at the 24-h time point (Fig. 5a). Although the
three miRNAs (miR-142-5p, miR-331-3p and miR-30a-
5p) were differentially regulated, only miR-142-5p was
consistently up-regulated in all three models. In contrast,
miR-331-3p and miR-30a-5p were up-regulated in the
chronic models and down-regulated in the 6-Hz model
at 24 h. Two miRNAs were specifically overlapping
between the pilocarpine and the 6-Hz model; miR-335-
3p was consistently up-regulated, while miR-218-2-3
showed a different regulation in both models (Fig. 5a).
There was no overlap between the two electrically stim-
ulated models at 24 h (Fig. 5a). Taken together, the
number of overlapping miRNAs between the acute and
chronic models was lower compared to the correspond-
ing miRNAs (33) between the two chronic models.
Furthermore, a detailed comparison of the chronic
models is shown in Fig. 5b. Among all significantly
deregulated miRNAs in both chronic models, only
miR-494-3p was consistently up-regulated under all
experimental conditions. The number of commonly
deregulated miRNAs was higher (36 miRNAs) at the
early (24 h) versus the late (28 days) time point (15
miRNAs, including miR-676, miR-467c/miR-467e, miR-
191, miR-669c and miR-181). The annotations for these
miRNAs are shown in the Supplementary Table 1.
Thirty-six miRNAs deregulated at the acute time point
(24 h) represent 36.4 and 41.4 % of all the deregulated
miRNAs in the pilocarpine and SSSE model, respective-
ly. Similarly, 15 miRNAs at the late time point
(28 days) represent 29.4 and 26.3 % of all deregulated
miRNAs in the pilocarpine and SSSE model, respective-
ly. These results indicate a larger overlap of the models
at the early time point compared to the later stage of
the model.
Analysis of the different time points in the acute
seizure model (6 Hz) revealed that only early time
points (3 and 6 h) displayed substantially more
deregulated miRNAs, while at later time points (24
and 72 h), only few miRNAs were deregulated
(Fig. 5c). The majority of miRNAs (146) were signifi-
cantly deregulated at the 6-h time point. Seventy-three
miRNAs were identified as overlapping at the earliest
time points representing 73.7 and 50 % of miRNAs
detected at 3 and 6 h, respectively. Of note, two
Fig. 2 Principal component analysis (PCA) based on all detected
miRNAs. Scores of the samples in the first and the second principal
components are shown. Clustering of samples of a animals of the pilo-
carpine model: 24 h and 28 days naïve versus 24 h and 28 days after
pilocarpine-induced status epilepticus (SE); b animals of the SSSE mod-
el: 24 h and 28 days naïve versus 24 h and 28 days following electrically
induced SE; c animals of the 6-Hz model: 0 (naïve), 3, 6, 24 and 72 h
following seizure induction
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miRNAs were commonly deregulated across all time
points of the 6-Hz model: miR-335-3p and miR-138-
5p. Taken together, our data show that the majority of
changes in differential miRNA expression were detected
within 24 h following the initial insult in the acute
seizure model.
Fig. 3 Unsupervised hierarchical clustering analysis for the expression
values of the differentially expressed miRNAs. miRNAs with FDRBH<
0.05 are shown. The red and green squares represent the up- and down-
regulated miRNAs, respectively. Animals from the control groups (naïve)
are labelled in turquoise and TLE animals are labelled in red. Heat map
showing miRNA expression in naïve mice (0 h) versus induced mice (a–
d). a pilocarpine-induced SE mice (24 h) (up-regulated miRNAs ratio>
0.5, down-regulated miRNAs ratio<−0.5). b Pilocarpine-induced SE
mice (28 days) (up-regulated miRNAs ratio >0.3, down-regulated
miRNAs ratio<−0.4). cElectrically induced SEmice (24 h) (up-regulated
miRNAs ratio >0.5, down-regulated miRNAs ratio<−0.4). d Electrically
induced SE mice (28 days) (up-regulated miRNAs ratio >0.4, down-
regulated miRNAs ratio<−0.3) (colour figure online)
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Up- and Down-Regulated miRNAs
Comparison of individual time points within each model
with their corresponding control groups revealed a num-
ber of differentially expressed miRNAs. All significantly
changed miRNAs (Benjamini and Hochberg corrected p
value <0.05) displaying a fold change (FC) of >1 were
defined as up-regulated miRNAs, whereas miRNAs with
a FC of <1 were defined as down-regulated (Fig. 6).
The Supplementary Tables 2, 3 and 4 summarise the
annotations of these differentially expressed miRNAs in
all three models analysed.
In both chronic SE models, the total number of miRNAs
with altered expression levels was higher at the early time
point (24 h) relative to the later stage of the model (28 days).
The absolute number of up- and down-regulatedmiRNAs was
similar for both pilocarpine and SSSE animals (Fig. 6a). In the
6-Hz model, a higher proportion of miRNAs were up-
regulated at early time points. Throughout all time points of
the acute model, only very fewmiRNAs were down-regulated
Fig. 4 Unsupervised hierarchical clustering analysis for the expression
values of the differentially expressed miRNAs. miRNAs with FDRBH<
0.05 are shown. Colour labelling for up- and down-regulated miRNAs as
well as for different animal groups as in Fig. 3. a Heat map showing
miRNA expression in naïve mice (0 h) versus single seizure mice (3 h)
(up-regulated miRNAs ratio >0.4, down-regulated miRNAs ratio<−0.4).
bHeat map showing miRNA expression in naïve mice (0 h) versus single
seizure mice (6 h) (up-regulated miRNAs ratio >0.3, down-regulated
miRNAs ratio<−0.5). c Heat map showing miRNA expression in naïve
mice (0 h) versus single seizure mice (24 h) (up-regulated miRNAs ratio
>0.2, down-regulated miRNAs ratio<−1.3). d Heat map showing
miRNA expression in naïve mice (0 h) versus single seizure mice
(72 h) (up-regulated miRNAs ratio >0.1, down-regulated miRNAs ratio
<−0.7)
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(three miRNAs were down-regulated at 3 and 8 h at 6 h
and none at 24 and 72 h) (Fig. 6 and Supplementary
Table 4). In addition, the total number of miRNAs with
altered expression was much higher at 3 and 6 h com-
pared with 24 and 72 h, respectively.
Real-Time PCRValidation of Differentially Expressed
miRNAs
To validate the differentially expressed miRNAs identified in
our microarray analysis, we used qPCR and focused on com-
monly deregulated miRNAs among all three models as well as
between the chronic models (Fig. 7). miRNA-142-5p com-
monly up-regulated at 24 h in all three models was success-
fully validated using qPCR. miRNA 331-3p and miRNA-30a-
5p are both showing small fold changes in the microarray
analysis and the expression levels in the qPCR were low, and
no statistical difference was obtained using qPCR between the
groups (data not shown). Next, we investigated miRNAs
commonly deregulated in the two chronic epilepsy models
24 h following SE. miRNA-2137, miRNA-212 and miR-142-
3p were significantly increased in comparison with the con-
trols in both chronic epileptic models confirming the micro-
array data. The highest level of up-regulation was observed for
miR-2137 at 24 h for pilocarpine and SSSE models (23-fold
and 12-fold, respectively) (Fig. 7).
Furthermore, the qPCR analysis revealed that the expres-
sion of miRNA-221, miRNA-222 and miRNA-135b-5p was
significantly increased in both chronic models at the 28-day
time point (Fig. 7). In the 6-Hz model, miRNA-34b-3p was
significantly up-regulated at 3 h, and miRNA-140-5p was
significantly up-regulated at 6 h (Fig. 7). Overall, deregulation
of selected miRNAs initially identified by microarray analysis
was confirmed by qPCR.
Pathway Analysis
In order to assess the impact of differentially expressed
miRNAs on cellular mechanisms, an enrichment analysis
was conducted for miRNA binding to genes belonging to all
canonical pathway maps of the MetaCore™ software suite
(http://thomsonreuters.com/site/systems-biology/). Only
Fig. 5 Venn diagram of all significantly deregulated miRNAs (FDRBH<
0.05) in the different models. a Venn diagram showing the overlap of
commonly deregulated miRNAs in 6 Hz, pilocarpine and SSSE model at
24 h following induction of seizure or SE. b Venn diagram showing
expression of deregulated miRNAs in the chronic pilocarpine and the
SSSE model at 24 h and 28 days following SE. c Venn diagram showing
deregulated miRNAs in the acute 6-Hz model at 3, 6, 24 and 72 h
following single seizure
Fig. 6 Differentially expressed miRNAs in the different mouse epilepsy
models. Data represent the absolute number of up-regulated (p value
>0.05 and FC>1) or down-regulated (p value >0.05 and FC<1) miRNAs
for each time point and in each model. a Deregulated miRNAs in the
pilocarpine and the SSSE model. b Deregulated miRNAs in the 6-Hz
model
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proven interactions with miRNAs recorded in MetaCore™
were considered.
When taking into account miRNAs down-regulated in both
the pilocarpine and the SSSE models at 24 h post-SE, several
pathways related to the mitochondrial metabolism were iden-
tified (data not shown). Table 1 shows the pathways linked
with miRNAs up-regulated under the different experimental
conditions. miRNAs up-regulated in samples from pilocarpine
animals 24 h post-SE were enriched in several pathways
associated with inflammation, such as IL-6, high-mobility
group box 1 (HMGB1) and innate immunity. Despite several
deregulated miRNAs, no strong correlation could be identi-
fied in the SSSE model relative to naïve animals. Neverthe-
less, miRNAs overexpressed in both pilocarpine and SSSE
animal 24 h post-SE were slightly enriched in the same
inflammation pathway even if not considered significant.
In the acute seizure samples, up-regulated miRNAs after
3 and 6 h were enriched in several pathways involved
in cell cycle regulation.
Discussion
miRNAs are important regulators of a plethora of pathophys-
iological processes, playing a prominent role in normal neu-
ronal function as well as neurodegenerative diseases (Im and
Kenny 2012; McNeill and Van Vactor 2012; Salta and De
Strooper 2012). Several genome-wide miRNA screens pro-
vided evidence that miRNAs are differentially expressed in a
variety of animal models of seizure (Aronica et al. 2010; Hu
et al. 2012; Omran et al. 2012). However, available epilepsy
animal models differ in several fundamental parameters such
as induction of seizure/SE, time of seizure onset, frequency
and severity of recurrent seizures, hippocampal sclerosis and
microglia activation. These parameters most likely influence
miRNA expression during different stages of epileptogenesis
(Jimenez-Mateos and Henshall 2013). So far, to our knowl-
edge, there is no comparative analysis of miRNA profiles in
chronic models of TLE and acute seizure models. The identi-
fication of miRNAs related to spontaneous seizures in contrast
to miRNAs deregulated in chronic stages of the disease is of
essence for mechanistic understanding. miRNAs that are
deregulated in the chronic phase are likely involved in funda-
mental processes of epileptogenesis and therefore interesting
candidates for new therapeutic approaches. In order to detect
miRNAs specific to disease progression and to distinguish
them from miRNAs related to acute seizures only, we com-
pared results from two chronic epilepsy models (pilocarpine
and SSSE) with those from the acute 6-Hz seizure model. All
three models used in our study share one important feature,
namely the focal onset of seizures and clear involvement of
temporal lobe structures (Barton et al. 2001; Mazzuferi et al.
2012). Therefore, miRNA profiling performed in the hippo-
campal samples obtained from these models should allow a
good comparison of spatiotemporal expression changes.
Analysis of the results from three models revealed a clear
separation in miRNA expression patterns in the acute single
seizure model (6 Hz) and the two chronic epilepsy models
(pilocarpine and SSSE). Thus, the induction of a single seizure
induces a different miRNA expression patterns when com-
pared to SRS following SE.
The high overlap of miRNAs at the early time point (24 h)
for pilocarpine and SSSE models observed in the heat maps
implies a certain similarity between both models, although
they are based on different stimuli (chemical versus electrical)
and were performed in different mouse strains (NMRI and
C57Bl/6). A study by Parsons et al. (2008) showed that only
~5 % of 166 investigated miRNAs were differentially
expressed in different mouse strains. Interestingly, some of
the commonmiRNAs identified in our analysis at 24 h such as
miR-27a and miR-146b are consistent with other post-SE
mouse models (Jimenez-Mateos et al. 2011). Importantly,
these miRNAs also show clear overlap with a rat TLE model
(miR-146a, miR-135b, miR-27a, miR-210, etc.) (Hu et al.
2012). These observations strongly indicate common miRNA
expression changes in response to SE, irrespective of the
model, species or strain, suggesting their involvement in the
epileptogenic process.
The 6-Hz single seizure model was designed to follow the
alteration of miRNA expression over 72 h and to compare the
expression pattern at 3, 6, 24 and 72 h with the starting point
(0 h). Although in this experimental setting there are no
individual controls for every time point, it allows for the
Fig. 7 RT-qPCR validation of deregulated miRNAs. The expression of
miRNAs which were identified as either up- or down-regulated 24 h and
28 days following SE in chronic epilepsy models and at 3, 6 and 24 h
following seizure in acute epilepsy model was analysed by RT-qPCR.
Data represent significant mean fold changes for N=8 animals per group
(p<0.05 calculated by Student’s t test). RT-qPCR reactions that were
performed in triplicates and fold changes were calculated by the ΔΔCt
method using U6 small RNA as housekeeping gene and normalisation to
control animal group. The controls were set as 1
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analysis of the time-course of miRNA changes after a single
seizure. The largest changes in this acute, single seizure model
occur immediately following seizure (3 and 6 h). Alterations
of miRNA expression return back to basal levels within 24 to
72 h in the 6-Hz model. This notion is further corroborated by
the observation that 17 miRNAs were deregulated at 24 h and
only 4 miRNAs were deregulated at 72 h.
For the overall comparison, the 24-h time point is of special
interest, since it is common to all three models. Although 36
miRNAs were overlapping among the two chronic models,
only three miRNAs overlapped between all models at 24 h.
Among the three commonly regulated miRNAs, miR-142-5p
is consistently up-regulated in all models. miR-142 is mainly
associated with the immune system and plays a crucial role in
myeloid (Chen et al. 2008; Wang et al. 2011) and macrophage
differentiation, as well as IL-6 signalling (Sonda et al. 2013).
Interestingly, our pathway analysis revealed a link between
the identified miRNA pattern with genes associated with
immune response in general and the IL-6 pathway in particu-
lar. Although the role of miR-142 in IL-6 regulation under
epileptic conditions is not clear, it might be consistent with a
role of this miRNA and IL-6 in epilepsy (Uludag et al. 2013)
as well as neuroinflammation in general (Vezzani et al. 2012).
We focused on commonly deregulated miRNAs in chronic
epilepsy models considering them as potentially relevant for
the pathophysiological changes related to chronic forms of
human epilepsy. The Venn diagrams show that 36 miRNAs
were commonly altered at 24 h, whereas only 15 miRNAs
were identified at 28 days. The majority of these miRNA
candidates were confirmed by qPCR indicating a closer sim-
ilarity in miRNA changes at early time points. Interestingly,
among these miRNAs, miR-135b was previously described in
Table 1 Pathway analysis conducted with the MetaCore™ tool
Pathways Pilocarpine SSSE 6 Hz Pilo vs SSSE 6 Hz







Cell adhesion_Ephrin signalling 0.062 0.038
Cannabinoid receptor signalling in nicotine
addiction
0.038
Cytoskeleton remodelling_Role of PKA in
cytoskeleton reorganisation
0.042
Cell cycle_Role of APC in cell cycle regulation 0.034 0.108
Apoptosis and survival_Lymphotoxin-beta
receptor signalling
0.114 0.018 0.087 0.102
Cell cycle_Regulation of G1/S transition (part 2) 0.010 0.105 0.005
Cell cycle_Cell cycle (generic schema) 0.002 0.177 0.012
Benzo[a]pyrene metabolism 0.095 0.136 0.040
Neurophysiological process_Thyroliberin in cell
hyper-polarisation and excitability
0.070 0.062 0.012
Blood coagulation_GPCRs in platelet aggregation 0.140 0.087 0.028
DNA damage_Inhibition of telomerase activity
and cellular senescence
0.034 0.201 0.012
Development_Alpha-1 adrenergic receptors signalling
via cAMP
0.001
Development_Adiponectin signalling 0.032 0.234 0.254
Immune response_Role of HMGB1 in dendritic cell
maturation and migration
0.014 0.240
Immune response_Role of PKR in stress-induced
antiviral cell response
0.024 0.207 0.268
Mucin expression in CF via IL-6, IL-17 signalling
pathways
0.028 0.185
Mucin expression in CF via TLRs, EGFR signalling
pathways
0.043 0.173
Immune response_HMGB1 release from the cell 0.002 0.111
Immune response_MIF in innate immunity response 0.042 0.173
FDR values are shown for pilocarpine (pilo), SSSE and 6-Hz comparisons
SSSE self-sustained status epilepticus
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the chronic stage of a rat TLE model (Hu et al. 2012). In
addition, individual miRNAs at 28 days revealed a high
overlap between our pilocarpine results and those from Hu
et al. (Hu et al. 2012).
The observation that more miRNAs are commonly
deregulated at 24 h than at 28 days is most probably due to
different biological processes that are relevant for the specific
time points (Riban et al. 2002). At 24 h, these include pro-
cesses such as cell death, inflammation and gliosis, whereas at
later stages of epileptogenesis, proliferation and sprouting of
neurons are of importance (Riban et al. 2002).
ThemiRNAmost consistently up-regulated in both chronic
models was miR-2137. The qPCR analysis revealed a more
than 12-fold increase of miR-2137 expression as compared
with control in the SSSE model and a more than 23-fold
increase in the pilocarpine model. Despite the increased ex-
pression of this miRNA in the acute phase of the SE models,
very little is known about the biological implication of this
miRNA in general. An additional complication in the analysis
of miR-2137 is the absence of a human homolog.
Interestingly, we identified several miRNAs in the chronic
phase of both models that have so far not been associated with
seizures, for example miR-676, miR-467c/miR-467e, miR-
191, miR-669c and miR-181. miR-181 regulates several
cancer-associated genes (Neel and Lebrun 2013), but its role
in astrocyte response to inflammatory stimuli (Hutchison et al.
2013) and regulation of GABA(A) receptors (Zhao et al.
2012) could be highly relevant for epilepsy.
miRNAs detected in our study have also been identified in
other epilepsy models validating our experimental approach.
For example, we confirmed the up-regulation of miR-146a,
already described in other profiling studies in animal models
and human epilepsy (Aronica et al. 2010; Hu et al. 2012;
Omran et al. 2012). miRNA-146a has been described as being
involved in astrocyte-mediated inflammatory response occur-
ring 24 h after SE in the pilocarpine model (Mazzuferi et al.
2012) (RK personal communication). Interestingly, miR-146a
is continuously up-regulated in the chronic phase of the SSSE
model when astrocytosis takes place (RK personal communi-
cation). miR-21-3p and miR-21-5p are also commonly up-
regulated in both post-SE models at 24 h. The expression of
these miRNAs is modulated in many biological processes and
in several pathological conditions and recently confirmed in
children with mesial temporal lobe epilepsy (mTLE) (Peng
et al. 2013). One possible mechanism linking these miRNAs
with epilepsy could be the previously described targeting of
the transcription factor myocyte enhancer factor 2C (MEF2C),
which has been associated with neuronal dysfunction and
neurodegeneration (Yelamanchili et al. 2010). Interestingly,
mutations in MEF2C gene have been identified in patients
with epilepsy (Paciorkowski et al. 2013). Moreover, miR-132
commonly up-regulated in the chronic models at 24 h for both
models and at 28 days for pilocarpine has been identified to be
increased in the CA3 region of animals 24 h post-SE. In
addition, antagomiR-mediated depletion of miR-132 in ani-
mals reduced seizure-induced neuronal loss confirming the
functional relevance of this miRNA in epilepsy (Jimenez-
Mateos et al. 2011).
During the chronic phase of the post-SE models, we con-
firmed two miRNAs that have been shown to be associated
with epilepsy in previous studies (Kan et al. 2012): miR-221
and miR-222. These two miRNAs were identified in profiling
studies of animal epilepsy models or human TLE profiling
studies (Kan et al. 2012) and shown to be down-regulated. In
contrast, miR-221 and miR-222 were consistently up-regulated
in our model. Both miRNAs are described to regulate the
expression of intercellular adhesion molecule 1 (ICAM1,
CD54) typically expressed on endothelial cells and cells of
the immune system. This is consistent with the occurrence of
neuroinflammation in a wide range of seizure syndromes
(Vezzani et al. 2011, 2012) and the anticonvulsant and neuro-
protective effect of anti-inflammatory treatment reducing
microglial activation in post-SEmodels (Mazzuferi et al. 2013).
Individual miRNAs can target several mRNAs and thus
affect entire pathways. A pathway analysis was performed on
miRNAs deregulated in both chronic models and the acute 6-
Hz model considering only proven miRNA-mRNA interac-
tions as recorded in MetaCore™. Interestingly, this analysis
revealed the regulation of several genes associated with inflam-
matory pathways such as IL-1β, IL-6 and HMGB1 in the early
phase of the pilocarpine model. Surprisingly, we could not
detect a similar association of inflammation with the early
phase of the SSSE model but a slight enrichment when
analysing the overlap of pilocarpine versus SSSE 24 h post-SE.
This prominent role of inflammatory pathways associated
with seizures is consistent with observations from other
groups describing active neuroinflammation in human epilep-
sy and animal seizure models. Among the variety of pro-
inflammatory mediators, several cytokines have been studied
in epilepsy. IL-1β exerts a pro-convulsive effect with wors-
ened and prolonged seizure activity in rodent epilepsy models
(Vezzani et al. 1999). Moreover, in brain tissue obtained from
patients with TLE, IL-1β expression and IL-1 receptor are
increased in astrocytes, microglia and neurons (Ravizza et al.
2008). For IL-6, pro-convulsive effects at high concentrations
have been described in animal models even though IL-6 is
necessary for the normal brain development (Lehtimaki et al.
2003). In humans, IL-6 increases significantly 24 h after
generalised tonic-clonic seizures in the plasma and CSF
(Peltola et al. 2000; Virta et al. 2002; Lehtimaki et al. 2007).
Several other mechanisms including TNF-α and Toll-like
receptor (TLR) signalling have been described in epilepsy
(for review, see Balosso et al. 2013).
HMGB1 exerts different biological functions depending on
its cellular localisation. HMGB1 can reach the extracellular
space via two different routes: active secretion by stimulated
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cells and passive release from necrotic and apoptotic cells.
HMBG1 is a member of the danger-associated molecular
pattern (DAMPs) molecules and can activate several receptors
including TLR4 and RAGE receptors that have pro-
convulsive activity (Iori et al. 2013).
Interestingly, the pathway analysis also identified changes
in cell cycle regulation after acute seizures in the 6-Hz model.
This is consistent with previous observations that found
neurogenesis and cell proliferation within the hippocampus
in response to seizure induction (Jessberger et al. 2005;
Siebzehnrubl and Blumcke 2008). Although the role of
neurogenesis in epilepsy pathophysiology is still controver-
sial, our results provide additional evidence for potential in-
volvement of miRNAs in this process.
In conclusion, our comprehensive miRNA profiling study
identified commonmiRNA signatures for the chronic epilepsy
models with a clear distinction from the pattern observed in
animals with a single seizure. The miRNAs that have also
been found in other epilepsy-based miRNA profiling studies,
together with newly identified miRNAs relevant to seizure
disorders, should help improve our understanding of funda-
mental processes involved in epilepsy as well as processes
leading to epileptogenesis. Our study could help elucidate
novel mechanisms and therapeutic approaches in epilepsy.
Acknowledgments This study was supported by the Neuroallianz Con-
sortium, part of the German Biopharma Initiative of the Federal Ministry of
Education and Research (BMBF). Michel Neveux and Karine Leclercq are
kindly acknowledged for excellent technical assistance in providing sam-
ples from mouse models. In addition, we thank Gundula Hesse for the
excellent technical assistance and Azita Tofighy for proof reading.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
Aravin A, Tuschl T (2005) Identification and characterization of small
RNAs involved in RNA silencing. FEBS Lett 579(26):5830–5840
Aronica E, Fluiter K et al (2010) Expression pattern of miR-146a, an
inflammation-associated microRNA, in experimental and human
temporal lobe epilepsy. Eur J Neurosci 31(6):1100–1107
Balosso S, Ravizza T et al (2013) The dual role of TNF-alpha and its
receptors in seizures. Exp Neurol 247C:267–271
Barton ME, Klein BD et al (2001) Pharmacological characterization of
the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy
Res 47(3):217–227
Benardo LS (2003) Epileptogenesis and neurogenesis share the same
genes. Epilepsy Curr 3(5):162–163
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a
practical and powerful approach to multiple testing. J R Stat Soc Ser
B Methodol 57(1):289–300
Casella G (1985) An introduction to empirical bayes data analysis. Am
Stat 39(2):83–87
Chen A, Luo M et al (2008) Complementary analysis of microRNA and
mRNA expression during phorbol 12-myristate 13-acetate (TPA)-in-
duced differentiation ofHL-60 cells. Biotechnol Lett 30(12):2045–2052
Forsgren L, Hauser WA et al (2005) Mortality of epilepsy in developed
countries: a review. Epilepsia 46(Suppl 11):18–27
Gentleman RC, Carey VJ et al (2004) Bioconductor: open software
development for computational biology and bioinformatics.
Genome Biol 5(10):R80
Gregory RI, Chendrimada TP et al (2006) MicroRNA biogenesis: isola-
tion and characterization of the microprocessor complex. Methods
Mol Biol 342:33–47
Griffiths-Jones S (2004) The microRNA registry. Nucleic Acids Res
32(Database issue):D109–D111
Griffiths-Jones S (2006) miRBase: the microRNA sequence database.
Methods Mol Biol 342:129–138
Griffiths-Jones S, Grocock RJ et al (2006) miRBase: microRNA se-
quences, targets and gene nomenclature. Nucleic Acids Res
34(Database issue):D140–D144
Griffiths-Jones S, Saini HK et al (2008) miRBase: tools for microRNA
genomics. Nucleic Acids Res 36(Database issue):D154–D158
Hu K, Xie YY et al (2012) MicroRNA expression profile of the hippo-
campus in a rat model of temporal lobe epilepsy and miR-34a-
targeted neuroprotection against hippocampal neurone cell apopto-
sis post-status epilepticus. BMC Neurosci 13:115
Hutchison ER, Kawamoto EM et al (2013) Evidence for miR-181 in-
volvement in neuroinflammatory responses of astrocytes. Glia
61(7):1018–1028
Hutvagner G, Zamore PD (2002) A microRNA in a multiple-turnover
RNAi enzyme complex. Science 297(5589):2056–2060
Im HI, Kenny PJ (2012) MicroRNAs in neuronal function and dysfunc-
tion. Trends Neurosci 35(5):325–334
Iori V, Maroso M et al (2013) Receptor for Advanced Glycation
Endproducts is upregulated in temporal lobe epilepsy and contrib-
utes to experimental seizures. Neurobiol Dis 58C:102–114
Jessberger S, Romer B et al (2005) Seizures induce proliferation and
dispersion of doublecortin-positive hippocampal progenitor cells.
Exp Neurol 196(2):342–351
Jimenez-Mateos EM, Henshall DC (2013) Epilepsy and microRNA.
Neuroscience 238:218–229
Jimenez-Mateos EM, Bray I et al (2011) miRNA expression profile after
status epilepticus and hippocampal neuroprotection by targeting
miR-132. Am J Pathol 179(5):2519–2532
Jimenez-Mateos E M, Engel T et al (2012) Silencing microRNA-134
produces neuroprotective and prolonged seizure-suppressive effects.
Nat Med
Kaminski RM, Livingood MR et al (2004) Allopregnanolone analogs
that positively modulate GABA receptors protect against partial
seizures induced by 6-Hz electrical stimulation in mice. Epilepsia
45(7):864–867
Kan A A, van Erp S et al (2012) Genome-wide microRNA profiling of
human temporal lobe epilepsy identifies modulators of the immune
response. Cell Mol Life Sci
Kobow K, Blumcke I (2011) The methylation hypothesis: do epigenetic
chromatin modifications play a role in epileptogenesis?”. Epilepsia
52(Suppl 4):15–19
Kosik KS (2006) The neuronal microRNA system. Nat Rev Neurosci
7(12):911–920
Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA
annotation and deep-sequencing data. Nucleic Acids Res
39(Database Issue)
Lee CT, Risom T et al (2007) Evolutionary conservation of microRNA
regulatory circuits: an examination of microRNA gene complexity
and conserved microRNA-target interactions through metazoan
phylogeny. DNA Cell Biol 26(4):209–218
478 J Mol Neurosci (2015) 55:466–479
Lehtimaki KA, Peltola J et al (2003) Expression of cytokines and cyto-
kine receptors in the rat brain after kainic acid-induced seizures.
Brain Res Mol Brain Res 110(2):253–260
Lehtimaki KA, Keranen T et al (2007) Increased plasma levels of cyto-
kines after seizures in localization-related epilepsy. Acta Neurol
Scand 116(4):226–230
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta C(T))
method. Methods 25(4):402–408
Loscher W, Schmidt D (2011) Modern antiepileptic drug development
has failed to deliver: ways out of the current dilemma. Epilepsia
52(4):657–678
Mazzuferi M, Kumar G et al (2012) Rapid epileptogenesis in the mouse
pilocarpine model: video-EEG, pharmacokinetic and histopatholog-
ical characterization. Exp Neurol 238(2):156–167
Mazzuferi M, Kumar G et al (2013) Nrf2 defense pathway: experimental
evidence for its protective role in epilepsy. Ann Neurol
McClelland S, Flynn C et al (2011) Neuron-restrictive silencer factor-
mediated hyperpolarization-activated cyclic nucleotide gated chan-
nelopathy in experimental temporal lobe epilepsy. Ann Neurol
70(3):454–464
McKiernan R C, Jimenez-Mateos E M et al (2012) Expression profiling
the microRNA response to epileptic preconditioning identifies miR-
184 as a modulator of seizure-induced neuronal death. Exp Neurol
McNeill E, Van Vactor D (2012) MicroRNAs shape the neuronal land-
scape. Neuron 75(3):363–379
Neel JC, Lebrun JJ (2013) Activin and TGFbeta regulate expression of
the microRNA-181 family to promote cell migration and invasion in
breast cancer cells. Cell Signal 25(7):1556–1566
Niespodziany I, Leclère N et al (2010) In vitro field potential recording
reveals enhanced neuronal excitability after the development of spon-
taneous seizures in the mouse model of self-sustained status epilepti-
cus. Society for Neuroscience Annual Meeting 55.6Q7. Online
Nikolsky Y, Ekins S et al (2005) A novel method for generation of
signature networks as biomarkers from complex high throughput
data. Toxicol Lett 158(1):20–29
Omran A, Peng J et al (2012) Interleukin-1beta and microRNA-146a in
an immature rat model and children with mesial temporal lobe
epilepsy. Epilepsia 53(7):1215–1224
Paciorkowski AR, Traylor RN et al (2013) MEF2C Haploinsufficiency
features consistent hyperkinesis, variable epilepsy, and has a role in
dorsal and ventral neuronal developmental pathways. Neurogenetics
14(2):99–111
Parsons MJ, Grimm CH et al (2008) Using hippocampal microRNA
expression differences between mouse inbred strains to characterise
miRNA function. Mamm Genome 19(7–8):552–560
Peltola J, Palmio J et al (2000) Interleukin-6 and interleukin-1 receptor
antagonist in cerebrospinal fluid from patients with recent tonic-
clonic seizures. Epilepsy Res 41(3):205–211
Peng J, Omran A et al (2013) Expression patterns of miR-124, miR-134,
miR-132, and miR-21 in an immature rat model and children with
mesial temporal lobe epilepsy. J Mol Neurosci 50(2):291–297
Pfeifer A, Lehmann H (2010) Pharmacological potential of RNAi - focus
on miRNA. Pharmacol Ther 126(3):217–227
Pillai RS (2005) MicroRNA function: multiple mechanisms for a tiny
RNA?”. RNA 11(12):1753–1761
RacineRJ (1972)Modification of seizure activity by electrical stimulation. II.
Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281–294
Rao Y, Lee Y et al (2008) A comparison of normalization techniques for
microRNAmicroarray data. Stat Appl Genet Mol Biol 7(1): Article22
Ravizza T, Noe F et al (2008) Interleukin converting enzyme inhibition
impairs kindling epileptogenesis in rats by blocking astrocytic IL-
1beta production. Neurobiol Dis 31(3):327–333
R Development Core Team (2011), R: A Language and Environment for
Statistical Computing. Vienna, Austria : the R Foundation for
Statistical Computing. Available online at http://www.R-project.org/
Riban V, Bouilleret V et al (2002) Evolution of hippocampal epileptic
activity during the development of hippocampal sclerosis in a mouse
model of temporal lobe epilepsy. Neuroscience 112(1):101–111
Risso D, Massa MS et al (2009) A modified LOESS normalization
applied to microRNA arrays: a comparative evaluation.
Bioinformatics 25(20):2685–2691
Ritchie ME, Silver J et al (2007) A comparison of background correction
methods for two-colour microarrays. Bioinformatics 23(20):2700–2707
Salta E, De Strooper B (2012) Non-coding RNAs with essential roles in
neurodegenerative disorders. Lancet Neurol 11(2):189–200
Schaefer A, O'Carroll D et al (2007) Cerebellar neurodegeneration in the
absence of microRNAs. J Exp Med 204(7):1553–1558
Schauwecker PE (2011) The relevance of individual genetic background
and its role in animal models of epilepsy. Epilepsy Res 97(1–2):1–11
Siebzehnrubl FA, Blumcke I (2008) Neurogenesis in the human hippo-
campus and its relevance to temporal lobe epilepsies. Epilepsia
49(Suppl 5):55–65
Silver JD, Ritchie ME et al (2009) Microarray background correction:
maximum likelihood estimation for the normal-exponential convo-
lution. Biostatistics 10(2):352–363
Smyth G K (2005) Limma: linear models for microarray data.
Bioinformatics 397–420
Smyth GK, Speed T (2003) Normalization of cDNA microarray data.
Methods 31(4):265–273
Sonda N, Simonato F et al (2013) miR-142-3p Prevents Macrophage
Differentiation during Cancer-Induced Myelopoiesis. Immunity
38(6):1236–49
Temkin NR (2009) Preventing and treating posttraumatic seizures: the
human experience. Epilepsia 50(Suppl 2):10–13
Turski WA, Cavalheiro EA et al (1983) Limbic seizures produced by
pilocarpine in rats: behavioural, electroencephalographic and neu-
ropathological study. Behav Brain Res 9(3):315–335
Uludag IF, Bilgin S et al (2013) Interleukin-6, interleukin-1 beta and
interleukin-1 receptor antagonist levels in epileptic seizures. Seizure
22(6):457–461
Vezzani A, Conti M et al (1999) Interleukin-1beta immunoreactivity and
microglia are enhanced in the rat hippocampus by focal kainate
application: functional evidence for enhancement of electrographic
seizures. J Neurosci 19(12):5054–5065
Vezzani A, Aronica E et al (2011) Epilepsy and brain inflammation. Exp
Neurol 244:11–21
Vezzani A, Balosso S et al (2012) Inflammation and epilepsy. Handb Clin
Neurol 107:163–175
Virta M, Hurme M et al (2002) Increased plasma levels of pro- and anti-
inflammatory cytokines in patients with febrile seizures. Epilepsia
43(8):920–923
Volvert ML, Rogister F et al (2012) MicroRNAs tune cerebral cortical
neurogenesis. Cell Death Differ 19(10):1573–1581
Wang F,Wang XS et al (2011) miR-29a and miR-142-3p downregulation
and diagnostic implication in human acute myeloid leukemia. Mol
Biol Rep 39(3):2713–2722
Weiss SR, Post RM et al (1986) CRF-induced seizures and behavior:
interaction with amygdala kindling. Brain Res 372(2):345–351
Williams PA, White AM et al (2009) Development of spontaneous
recurrent seizures after kainate-induced status epilepticus. J
Neurosci 29(7):2103–2112
Yang YH, Dudoit S et al (2002) Normalization for cDNA microarray
data: a robust compositemethod addressing single andmultiple slide
systematic variation. Nucleic Acids Res 30(4):e15
Yelamanchili SV, Chaudhuri AD et al (2010) MicroRNA-21 dysregulates
the expression of MEF2C in neurons in monkey and human SIV/
HIV neurological disease. Cell Death Dis 1:e77
Zhao C, Huang C et al (2012) Computational prediction of MicroRNAs
targeting GABA receptors and experimental verification of miR-
181, miR-216 and miR-203 targets in GABA-A receptor. BMC Res
Notes 5:91
J Mol Neurosci (2015) 55:466–479 479
